Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22614176)

  • 1. Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2.
    Rosato P; Anastasiadou E; Garg N; Lenze D; Boccellato F; Vincenti S; Severa M; Coccia EM; Bigi R; Cirone M; Ferretti E; Campese AF; Hummel M; Frati L; Presutti C; Faggioni A; Trivedi P
    Leukemia; 2012 Nov; 26(11):2343-52. PubMed ID: 22614176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma.
    Leopizzi M; Mundo L; Messina E; Campolo F; Lazzi S; Angeloni A; Marchese C; Leoncini L; Giordano C; Slack F; Trivedi P; Anastasiadou E
    Blood; 2024 Feb; 143(5):429-443. PubMed ID: 37847858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.
    Wood CD; Carvell T; Gunnell A; Ojeniyi OO; Osborne C; West MJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas.
    Anastasiadou E; Stroopinsky D; Alimperti S; Jiao AL; Pyzer AR; Cippitelli C; Pepe G; Severa M; Rosenblatt J; Etna MP; Rieger S; Kempkes B; Coccia EM; Sui SJH; Chen CS; Uccini S; Avigan D; Faggioni A; Trivedi P; Slack FJ
    Leukemia; 2019 Jan; 33(1):132-147. PubMed ID: 29946193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
    Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
    Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.
    Motsch N; Pfuhl T; Mrazek J; Barth S; Grässer FA
    RNA Biol; 2007 Nov; 4(3):131-7. PubMed ID: 18347435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amino acid region 248-382 of the Epstein-Barr virus nuclear protein 2 (EBNA2) is responsible for the EBNA2-induced EBV reactivation.
    Fujiwara S; Liu E; Shimizu K
    Virus Genes; 2001 Dec; 23(3):361-5. PubMed ID: 11778704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
    J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
    Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
    J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
    Peng R; Moses SC; Tan J; Kremmer E; Ling PD
    J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
    Murray RJ; Young LS; Calender A; Gregory CD; Rowe M; Lenoir GM; Rickinson AB
    J Virol; 1988 Mar; 62(3):894-901. PubMed ID: 2828684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
    Kempkes B; Zimber-Strobl U; Eissner G; Pawlita M; Falk M; Hammerschmidt W; Bornkamm GW
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.
    Farrell CJ; Lee JM; Shin EC; Cebrat M; Cole PA; Hayward SD
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4625-30. PubMed ID: 15070768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.
    Kelly GL; Milner AE; Tierney RJ; Croom-Carter DS; Altmann M; Hammerschmidt W; Bell AI; Rickinson AB
    J Virol; 2005 Aug; 79(16):10709-17. PubMed ID: 16051863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.
    Kohlhof H; Hampel F; Hoffmann R; Burtscher H; Weidle UH; Hölzel M; Eick D; Zimber-Strobl U; Strobl LJ
    Blood; 2009 May; 113(22):5506-15. PubMed ID: 19339697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
    Billaud M; Rousset F; Calender A; Cordier M; Aubry JP; Laisse V; Lenoir GM
    Blood; 1990 May; 75(9):1827-33. PubMed ID: 1691936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
    Ning S; Hahn AM; Huye LE; Pagano JS
    J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.
    Lucchesi W; Brady G; Dittrich-Breiholz O; Kracht M; Russ R; Farrell PJ
    J Virol; 2008 Aug; 82(15):7456-66. PubMed ID: 18480445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.